Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11267868 Fc region variant

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
April 2, 2014
Date of Patent
March 8, 2022
Patent Application Number
14781069
Patent Citations
‌
US Patent 10253100 Therapeutic antigen-binding molecule with a FcRn-binding domain that promotes antigen clearance
‌
US Patent 10472623 Antigen-binding molecule capable of binding two or more antigen molecules repeatedly
‌
US Patent 10519229 Nucleic acids encoding IL-8 antibodies
‌
US Patent 10618965 Method for altering plasma retention and immunogenicity of antigen-binding molecule
‌
US Patent 10766960 Heterodimerized polypeptide
‌
US Patent 10738111 Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use
‌
US Patent 10919953 FcgammaRIIB-specific Fc region variant
‌
US Patent 10000560 Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use
‌
US Patent 10024867 Ion concentration-dependent binding molecule library
Patent Citations Received
‌
US Patent 12084513 Anti-C1S antibodies and methods of use
0
‌
US Patent 11780910 Anti-ANGPTL3 antibodies suitable for high concentration compositions and subcutaneous administration
‌
US Patent 11780912 Composition for prophylaxis or treatment of IL-8 related diseases
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11267868
Patent Primary Examiner
‌
Chun W Dahle

Find more entities like US Patent 11267868 Fc region variant

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo